Werewolf Therapeutics, Inc.
USD0.31
-0.01 (-4.64%)
CEO
Daniel J. Hicklin
IPO Date
2021-04-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.33
Prev. Close
$0.32
Day Low
$0.27
Day High
$0.34
52W Low
$0.27
52W High
$2.38
Market Cap
$0.01B
Volume
2.37M
| -0.9 |
| 31 Dec 2023 | FY | 91.2% | -187.4% | -33.6% | -21.4% | 0.47 | 7.14 | -3.7 |
| 31 Dec 2022 | FY | 84.7% | -328.1% | -44.0% | -33.6% | 0.12 | 5.84 | -1.1 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -32.7% | -27.9% | 0.10 | 13.56 | -4.4 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -16.7% | -15.5% | 0.03 | 17.58 | -30.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -112.5% | -50.7% | 0.32 | 8.84 | -42.0 |
| -0.9 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -55.3% | -20.6% | 1.26 | 3.87 | -1.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -43.4% | -19.4% | 0.90 | 5.30 | -0.7 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -31.6% | -16.9% | 0.65 | 8.09 | -0.6 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -27.8% | -16.1% | 0.51 | 7.45 | -0.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -18.7% | -11.9% | 0.41 | 10.10 | -1.4 |
| 30 Jun 2024 | Q2 | 60.3% | -1509.1% | -16.6% | -11.2% | 0.35 | 12.13 | -1.5 |
| 31 Mar 2024 | Q1 | 37.5% | -2182.3% | -13.8% | -9.1% | 0.44 | 6.71 | -4.1 |
| 31 Dec 2023 | Q4 | 69.4% | -799.7% | -10.8% | -6.9% | 0.47 | 7.14 | -2.9 |